Sepsis at Intensive Care Unit
7
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (7)
EEG Changes and Cognitive Profiles in Sepsis Patients With Different Inflammatory Phenotypes
Adjunctive Fludrocortisone in Septic Shock
Written Sepsis Education for Patients
Hemodynamic Venous Congestion Ultrasound (VExUS) by ICU Nurses in Sepsis Patients.
Role of Transposable Elements in Septic Immune Aging
Clinical Study Evaluating the Efficacy and Safety of Colchicine in Adult Patients With Sepsis
Validation of a Urinary Biomarker as Diagnostic Tool for AKI in Sepsis